Metropolis Healthcare (NSE:METROPOLIS) FFO


NSE:METROPOLIS Metropolis Healthcare Ltd NSE:METROPOLIS
95 GF Score
Price ₹567.95
GF Value ₹588.25
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Metropolis Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

NSE:METROPOLIS
95GF Score
Metropolis Healthcare Ltd NSE:METROPOLIS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Metropolis Healthcare (NSE:METROPOLIS) Overvalued in 2026?

Based on GuruFocus' analysis, Metropolis Healthcare stock appears to be undervalued. The current stock price of ₹567.95 is trading 3.5% below its estimated GF Value™ of ₹588.25. GuruFocus considers Metropolis Healthcare to be Fairly Valued.

Key valuation signals for NSE:METROPOLIS:

  • FFO:
  • GF Value™: ₹588.25 vs. price of ₹567.95 (3.5% below fair value)
  • GF Score™: 95/100 with 4 warning signs

No single metric tells the full story. See the NSE:METROPOLIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Metropolis Healthcare Business Description

Other Exchanges 542650:India
Address Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
95GF Score

Get the complete analysis for NSE:METROPOLIS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹567.95
Price
₹588.25
GF Value